MedAvante Central Ratings Selected For Cerecor Investigational MDD Study

Published December 3, 2013

MedAvante Central Ratings Selected For Cerecor Investigational MDD Study

Filed under: Maryland Drug Treatment Centers

"A new treatment with potential for rapid onset of action for severely depressed, treatment resistant patients is urgently needed," said James Vornov, MD, PhD, Cerecor SVP, Clinical Development and Regulatory Affairs. … "Because we provide a smaller …
Read more on PR Newswire (press release)

CardioBuzz: Earthquake Woes Include Cardiac Arrest

Filed under: Maryland Drug Treatment Centers

Previous research has identified a relationship between earthquakes and the risk of sudden cardiac arrest, and Taku Iwami, MD, PhD, of the Kyoto University Health Service in Japan, and colleagues wanted to find out whether a similar association was …
Read more on MedPage Today

Coumadin, Clinton, and corporate conspired conformity

Filed under: Maryland Drug Treatment Centers

After speaking with the neurologist in charge of Clinton's care, Marc Siegel, MD, of Fox News wrote: “Since she suffered another blood clot in …. Likewise, AHA/ACC recently issued cardiovascular risk reduction guidelines that call for statin drug …
Read more on HealthNewsReview.org